Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension

By sjmartinez • March 27, 2025

Channick R, Medrek S, Delcroix M, Gaine S, Jansa P, Lang I, McLaughlin V, Mehta S, Pulido T, Sastry B, Souza R, Torbicki A, Zhao C, Strachan P, Agron P, Yen J, Sitbon O. Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension. JHLT Open. 2025 Jan 16;7:100197. doi: 10.1016/j.jhlto.2024.100197. PMID: 40144855; PMCID: PMC11935431.

Tags: GRIPHON, Macitentan, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, Selexipag, SERAPHIN

Insurance-Based Disparities in Cardiac Allograft Vasculopathy After Heart Transplantation Are Mediated by Care at High-Volume Centers

Sakowitz S, Bakhtiyar SS, Mallick S, Pereira S, Nelson JS, Parikh R, Higgins RSD, Shemin RJ, Benharash P. Insurance-Based Disparities in Cardiac Allograft Vasculopathy After[...]

Engineering noncovalent π-stacked organic framework for intrinsic near-infrared photoactivated drug delivery

Fu R, Meng D, Han X, Liu L, Chen C, Zheng R, Zhao Y, Zhang X, Lin X, Hasani M, Song Y, Liang T, Wen[...]

Early U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair System: Insights From Real-World Data

Waggoner T, Garcia S, Chakravarty T, Makar M, Latib A, Kipperman RM, Zahr F, Hanson I, Sinha AK, Sharma RP, Depta JP, Castellanos JA, Kodali[...]